Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.994
+0.034 (3.51%)
Nov 20, 2024, 4:00 PM EST - Market closed

Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $41.24 million. The enterprise value is -$33.67 million.

Market Cap 41.24M
Enterprise Value -33.67M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

Rallybio has 41.49 million shares outstanding. The number of shares has increased by 8.55% in one year.

Current Share Class 41.49M
Shares Outstanding 41.49M
Shares Change (YoY) +8.55%
Shares Change (QoQ) +1.05%
Owned by Insiders (%) 5.58%
Owned by Institutions (%) 26.81%
Float 18.98M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 70.71
Forward PS n/a
PB Ratio 0.58
P/TBV Ratio 0.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.55, with a Debt / Equity ratio of 0.00.

Current Ratio 9.55
Quick Ratio 9.18
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -68.90% and return on invested capital (ROIC) is -42.74%.

Return on Equity (ROE) -68.90%
Return on Assets (ROA) -39.29%
Return on Capital (ROIC) -42.74%
Revenue Per Employee $13,907
Profits Per Employee -$1.56M
Employee Count 43
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -50.05% in the last 52 weeks. The beta is -1.67, so Rallybio's price volatility has been lower than the market average.

Beta (5Y) -1.67
52-Week Price Change -50.05%
50-Day Moving Average 1.07
200-Day Moving Average 1.44
Relative Strength Index (RSI) 43.76
Average Volume (20 Days) 70,041

Short Selling Information

The latest short interest is 463,356, so 1.12% of the outstanding shares have been sold short.

Short Interest 463,356
Short Previous Month 536,633
Short % of Shares Out 1.12%
Short % of Float 2.44%
Short Ratio (days to cover) 5.75

Income Statement

In the last 12 months, Rallybio had revenue of $598,000 and -$66.97 million in losses. Loss per share was -$1.57.

Revenue 598,000
Gross Profit 6.10M
Operating Income -66.70M
Pretax Income -73.88M
Net Income -66.97M
EBITDA -66.56M
EBIT -66.70M
Loss Per Share -$1.57
Full Income Statement

Balance Sheet

The company has $75.14 million in cash and $230,000 in debt, giving a net cash position of $74.91 million or $1.81 per share.

Cash & Cash Equivalents 75.14M
Total Debt 230,000
Net Cash 74.91M
Net Cash Per Share $1.81
Equity (Book Value) 70.82M
Book Value Per Share 1.71
Working Capital 70.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.07 million and capital expenditures -$12,000, giving a free cash flow of -$51.08 million.

Operating Cash Flow -51.07M
Capital Expenditures -12,000
Free Cash Flow -51.08M
FCF Per Share -$1.23
Full Cash Flow Statement

Margins

Gross Margin 1,019.40%
Operating Margin -11,153.85%
Pretax Margin -11,199.50%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -18,061.20%

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.55%
Shareholder Yield -8.55%
Earnings Yield -162.39%
FCF Yield -123.84%

Analyst Forecast

The average price target for Rallybio is $8.10, which is 714.81% higher than the current price. The consensus rating is "Buy".

Price Target $8.10
Price Target Difference 714.81%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Rallybio has an Altman Z-Score of -1.2 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.2
Piotroski F-Score 1